The role of adherence to antiretroviral therapy in the management of HIV infection.
about
Combination prevention: new hope for stopping the epidemicDesign of a randomized trial to evaluate the influence of mobile phone reminders on adherence to first line antiretroviral treatment in South India--the HIVIND study protocolThe role of jails in engaging PLWHA in care: from jail to community.Basic quinolinonyl diketo acid derivatives as inhibitors of HIV integrase and their activity against RNase H function of reverse transcriptase.Two-way text messaging for health behavior change among human immunodeficiency virus-positive individuals.Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies.Buffering effects of general and medication-specific social support on the association between substance use and HIV medication adherencePatients' worries before starting antiretroviral therapy and their association with treatment adherence and outcomes: a prospective study in rural Uganda, 2004 - 2009.Information-motivation-behavioral skills barriers associated with intentional versus unintentional ARV non-adherence behavior among HIV+ patients in clinical care.Chemokine (C-C motif) receptor 5 -2459 genotype in patients receiving highly active antiretroviral therapy: race-specific influence on virologic successInfluence of quinacrine and chloroquine on the in vitro 3'-azido-3'-deoxythymidine antiretroviral effect.Comparative description of haplotype structure and genetic diversity of MDR1 (ABCB1) in HIV-positive and HIV-negative populations.Switch from a ZDV/3TC-based regimen to a completely once daily (QD) regimen of emtricitabine/tenofovir DF fixed dose combination plus a third QD agent (SONETT)Worldwide variation in human drug-metabolism enzyme genes CYP2B6 and UGT2B7: implications for HIV/AIDS treatment.Duration of Antiretroviral Therapy Adherence Interruption Is Associated With Risk of Virologic Rebound as Determined by Real-Time Adherence Monitoring in Rural Uganda.Use of and Adherence to Antiretroviral Therapy in a Large U.S. Sample of HIV-infected Adults in Care, 2007-2008.Steady-state pharmacokinetics of abacavir in plasma and intracellular carbovir triphosphate following administration of abacavir at 600 milligrams once daily and 300 milligrams twice daily in human immunodeficiency virus-infected subjects.Factors related to quality of life in treatment-adherent, successfully treated HIV patients in France.Selecting anti-HIV therapies based on a variety of genomic and clinical factors.Personal barriers to antiretroviral therapy adherence: case studies from a rural Uganda prospective clinical cohort.Adherence to antiretroviral medication in older adults living with HIV/AIDS: a comparison of alternative models.Expanding antiretroviral options in resource-limited settings--a cost-effectiveness analysis.Discontinuation of antiretroviral therapy among adults receiving HIV care in the United States.The CASTLE study: atazanavir/r versus lopinavir/r in antiretroviral-naive patients.Antiretroviral therapy prescribing in hospitalized HIV clinic patients.Medication errors in HIV-infected hospitalized patients: a pharmacist's impact.Cell Phone-Based and Adherence Device Technologies for HIV Care and Treatment in Resource-Limited Settings: Recent Advances.Evaluating patient preference and satisfaction for human immunodeficiency virus therapy in FranceEfficacy and safety of atazanavir/ritonavir-based antiretroviral therapy for HIV-1 infected subjects: a systematic review and meta-analysis.The charms and challenges of antiretroviral therapy in Uganda: the DART experience.Adherence to On-Time ART Drug Pick-Up and Its Association with CD4 Changes and Clinical Outcomes Amongst HIV Infected Adults on First-Line Antiretroviral Therapy in Nigerian Hospitals.Perceived stigma among patients receiving antiretroviral treatment: a prospective randomised trial comparing an m-DOT strategy with standard-of-care in Kenya."Life-Steps" for PrEP Adherence: Demonstration of a CBT-Based Intervention to Increase Adherence to Preexposure Prophylaxis (PrEP) Medication Among Sexual-Minority Men at High Risk for HIV Acquisition.A Two-Way Steady-State Pharmacokinetic Interaction Study of Doravirine (MK-1439) and Dolutegravir.Which adherence measure - self-report, clinician recorded or pharmacy refill - is best able to predict detectable viral load in a public ART programme without routine plasma viral load monitoring?Factors contributing to antiretroviral drug adherence among adults living with HIV or AIDS in a Kenyan rural community.Depression, adherence and attrition from care in HIV-infected adults receiving antiretroviral therapy.Pharmacotoxicology of monocyte-macrophage nanoformulated antiretroviral drug uptake and carriageDirect monthly highly active antiretroviral therapy supply - a method to increase patient's adherence and outcome. Experience of one AIDS centre in Israel.The Acceptability and Perceived Usefulness of a Weekly Clinical SMS Program to Promote HIV Antiretroviral Medication Adherence in KwaZulu-Natal, South Africa.
P2860
Q24630559-E6491B7F-5A79-45BF-95A0-FF7820FCCC41Q33546692-16F8A670-AA03-4BA0-8B66-B5371228F744Q33858977-C76164B6-5A54-48F3-B1BC-5B521F3BC786Q34372481-25406429-D601-4475-9457-A2EB91C265D2Q34514824-F2112A28-E767-4ADE-9DE1-04253D9C0ED8Q34605871-D002FB81-71A1-4C1B-867A-ED2A1502C096Q34624889-72B90B99-3BD1-4C47-9953-68DD2C221AD7Q34708958-2E2451C5-7C15-443F-86FF-4545B6169A69Q34856063-94AFA754-55D5-4382-B4F9-E41A6AC32DBDQ35043700-1642683F-DC3C-4E86-B301-C19AACA6CDD1Q35191410-81E75DC9-342F-4E15-A55F-E8F1746AE874Q35295887-F28ACF75-387A-4A6C-A201-E58016058037Q35959086-A3ED07A1-E410-454C-9878-D981A3052633Q36079108-07691039-AC8A-40EF-A20A-0B7B77EF05FDQ36219891-EA1FFEFC-C2DC-4184-A700-E9611A72B488Q36302253-BBBF0A52-75B4-4CF3-866C-49E284947F99Q37144895-15504C51-0305-4DE3-9B9D-B443F52C4E91Q37232550-66C93FFB-1964-4564-BF6B-A828239DB805Q37283246-36C1EE2A-CE64-45A1-B5C5-07579B7C5C06Q37299197-C7627E4B-E009-4514-B010-0E9FEF81FFF1Q37329934-404EBBD6-B03B-4C23-A061-370A2880BCBCQ37375398-FA9378B9-B051-475D-895F-D3CFB6403BD6Q37388428-1C47F428-4CAE-4FC9-B148-88D71F3767F3Q37593100-3B4D1F8E-BA7A-4FC4-A2BC-5B2B8E51CD34Q37976563-E583D322-5AC7-4386-984C-5112DF862F31Q38112091-850DA99F-81A6-4B7E-AD19-308B0EDA22DDQ38600117-A1A0A8AF-E1D0-49EF-8371-8BC1A083F701Q38661423-9D4AC3E6-F662-490A-8F73-9AAD29C13FB7Q38865547-6C18C462-0F77-49A5-BF0E-4634C1DFCB35Q38869728-ED2CDBB1-8E1D-40EB-A17E-D508C066AAC2Q38889138-E32DED83-8D8C-4006-AC6F-A5A9793007FCQ39114150-3874A6F7-6D51-4D6A-980C-63C5C0D90802Q40251251-9BC921B5-C1A4-4687-B764-ABBF8EAE54D4Q40517770-CF17330A-9530-4583-ACF6-A178294A0F6FQ40697700-66063B3B-75DB-4FEF-AB5F-0DB6BD1CF616Q41481676-24968D34-FE1D-41E6-921E-8D9A09560571Q41668494-22AABD57-DCD5-4FC5-96B8-CA382CC6B8B6Q42116659-9B8F1506-315B-4348-8AA0-40AC2A12C30BQ42248267-EDB3C078-18CD-4EC7-AF2F-54C8371EFDA0Q42655926-54488BCD-61FE-4F64-8BCB-D4E6EAAEA8B1
P2860
The role of adherence to antiretroviral therapy in the management of HIV infection.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The role of adherence to antiretroviral therapy in the management of HIV infection.
@en
type
label
The role of adherence to antiretroviral therapy in the management of HIV infection.
@en
prefLabel
The role of adherence to antiretroviral therapy in the management of HIV infection.
@en
P1476
The role of adherence to antiretroviral therapy in the management of HIV infection.
@en
P2093
Brian Conway
P356
10.1097/QAI.0B013E3180600766
P407
P478
45 Suppl 1
P577
2007-06-01T00:00:00Z